Literature DB >> 16458793

What can geography tell us about prostate cancer?

Ann C Klassen1, Elizabeth A Platz.   

Abstract

One of the most striking characteristics of prostate cancer is the degree of geographic variation in its patterns of occurrence and progression; this variation is apparent at local, national, and international levels. Although geographic theory, methods, and data are increasingly utilized for public health research, epidemiologic research in prostate cancer etiology and progression has not taken full advantage of the spatial sciences as partner disciplines. This article reviews the known factors influencing the biology and epidemiology of prostate cancer and some of the ways in which findings to date have benefited from geography. A model is presented for geographically integrated research in prostate cancer, with discussion of how spatially referenced data and methods could enhance approaches to answering remaining questions in prostate cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16458793     DOI: 10.1016/j.amepre.2005.09.004

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  11 in total

1.  Night-Shift Work and Risk of Prostate Cancer: Results From a Canadian Case-Control Study, the Prostate Cancer and Environment Study.

Authors:  Christine Barul; Hugues Richard; Marie-Elise Parent
Journal:  Am J Epidemiol       Date:  2019-10-01       Impact factor: 4.897

2.  Development of animal models underlining mechanistic connections between prostate inflammation and cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  World J Clin Oncol       Date:  2013-02-10

3.  Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts
Journal:  J Health Care Poor Underserved       Date:  2011

4.  A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer.

Authors:  Gemma Llaverias; Christiane Danilo; Yu Wang; Agnes K Witkiewicz; Kristin Daumer; Michael P Lisanti; Philippe G Frank
Journal:  Am J Pathol       Date:  2010-11-18       Impact factor: 4.307

5.  Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Georges Adunlin; Askal Ayalew Ali; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2014-12-26

6.  Feasibility and utility of mapping disease risk at the neighbourhood level within a Canadian public health unit: an ecological study.

Authors:  Eric J Holowaty; Todd A Norwood; Susitha Wanigaratne; Juanjo J Abellan; Linda Beale
Journal:  Int J Health Geogr       Date:  2010-05-10       Impact factor: 3.918

7.  Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium.

Authors:  Charlotte Salmon; Lixin Song; Kenneth Muir; Nora Pashayan; Alison M Dunning; Jyotsna Batra; Suzanne Chambers; Janet L Stanford; Elaine A Ostrander; Jong Y Park; Hui-Yi Lin; Olivier Cussenot; Géraldine Cancel-Tassin; Florence Menegaux; Emilie Cordina-Duverger; Manolis Kogevinas; Javier Llorca; Radka Kaneva; Chavdar Slavov; Azad Razack; Jasmine Lim; Manuela Gago-Dominguez; Jose Esteban Castelao; Zsofia Kote-Jarai; Rosalind A Eeles; Marie-Élise Parent
Journal:  Eur J Epidemiol       Date:  2021-07-18       Impact factor: 8.082

8.  Race-specific geography of prostate cancer incidence.

Authors:  Laurie M DeChello; David I Gregorio; Holly Samociuk
Journal:  Int J Health Geogr       Date:  2006-12-18       Impact factor: 3.918

9.  Occupational exposure to polycyclic aromatic hydrocarbons and risk of prostate cancer.

Authors:  Christine Barul; Marie-Elise Parent
Journal:  Environ Health       Date:  2021-06-21       Impact factor: 5.984

10.  Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival.

Authors:  Kimberly D van der Willik; Liliana P Rojas-Saunero; Jeremy A Labrecque; M Arfan Ikram; Sanne B Schagen; Bruno H Stricker; Rikje Ruiter
Journal:  Eur J Epidemiol       Date:  2019-12-20       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.